Skip to main content
Premium Trial:

Request an Annual Quote

More to Do

The US Department of Defense still has not come up with a way to assess biosecurity measures at military labs, the New York Times reports.

In 2015, federal agencies investigated shipments of live anthrax from the Dugway Proving Ground, an Army facility, to other US locations as well as to Australia, Canada, and South Korea, and the initial investigation found fault with the procedures in place at the facility, as the approach used was not sufficient to kill the samples. The Times adds that a later finding also criticized a "culture of complacency" among senior managers at the facility.

A new report from the Government Accountability Office has found that the Defense Department has only implemented 18 of the 35 recommendations the Army made to improve safe handling of dangerous agents, the Times says. It notes that one of the recommendations still to be implemented is the development of a way to measure the effectiveness of the changes. This makes it difficult to gauge whether there have been safety improvements, it adds.

According to the Times, the Department of Defense has acknowledged the issue.

Concerns surrounding the handling of infectious agents by military labs arose around the same time as reports of the mishandling of smallpox samples at an old National Institutes of Health lab and of anthrax and flu samples by Centers for Disease Control and Prevention labs.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.